PMC:7160614 / 18414-19598 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"245","span":{"begin":30,"end":38},"obj":"Species"},{"id":"246","span":{"begin":100,"end":108},"obj":"Species"},{"id":"247","span":{"begin":175,"end":183},"obj":"Species"},{"id":"248","span":{"begin":428,"end":436},"obj":"Species"},{"id":"249","span":{"begin":566,"end":574},"obj":"Species"},{"id":"250","span":{"begin":720,"end":728},"obj":"Species"},{"id":"251","span":{"begin":46,"end":54},"obj":"Disease"},{"id":"252","span":{"begin":91,"end":99},"obj":"Disease"},{"id":"253","span":{"begin":166,"end":174},"obj":"Disease"},{"id":"254","span":{"begin":419,"end":427},"obj":"Disease"},{"id":"255","span":{"begin":557,"end":565},"obj":"Disease"},{"id":"256","span":{"begin":711,"end":719},"obj":"Disease"},{"id":"257","span":{"begin":964,"end":981},"obj":"Disease"},{"id":"258","span":{"begin":1151,"end":1159},"obj":"Disease"},{"id":"259","span":{"begin":1168,"end":1176},"obj":"Disease"}],"attributes":[{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"Tax:9606"},{"id":"A246","pred":"tao:has_database_id","subj":"246","obj":"Tax:9606"},{"id":"A247","pred":"tao:has_database_id","subj":"247","obj":"Tax:9606"},{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"Tax:9606"},{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"Tax:9606"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"Tax:9606"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"MESH:C000657245"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"MESH:C000657245"},{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"MESH:C000657245"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"MESH:C000657245"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"MESH:C000657245"},{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"MESH:C000657245"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:D010996"},{"id":"A258","pred":"tao:has_database_id","subj":"258","obj":"MESH:C000657245"},{"id":"A259","pred":"tao:has_database_id","subj":"259","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T39","span":{"begin":75,"end":80},"obj":"Body_part"},{"id":"T40","span":{"begin":683,"end":687},"obj":"Body_part"},{"id":"T41","span":{"begin":830,"end":844},"obj":"Body_part"},{"id":"T43","span":{"begin":1093,"end":1097},"obj":"Body_part"}],"attributes":[{"id":"A39","pred":"fma_id","subj":"T39","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma13121"},{"id":"A42","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma67480"},{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T28","span":{"begin":75,"end":80},"obj":"Body_part"},{"id":"T29","span":{"begin":683,"end":687},"obj":"Body_part"},{"id":"T30","span":{"begin":964,"end":981},"obj":"Body_part"},{"id":"T31","span":{"begin":1045,"end":1051},"obj":"Body_part"},{"id":"T32","span":{"begin":1093,"end":1097},"obj":"Body_part"}],"attributes":[{"id":"A28","pred":"uberon_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A29","pred":"uberon_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A30","pred":"uberon_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"A31","pred":"uberon_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T74","span":{"begin":46,"end":54},"obj":"Disease"},{"id":"T75","span":{"begin":91,"end":99},"obj":"Disease"},{"id":"T76","span":{"begin":166,"end":174},"obj":"Disease"},{"id":"T77","span":{"begin":419,"end":427},"obj":"Disease"},{"id":"T78","span":{"begin":557,"end":565},"obj":"Disease"},{"id":"T79","span":{"begin":711,"end":719},"obj":"Disease"},{"id":"T80","span":{"begin":1151,"end":1159},"obj":"Disease"},{"id":"T81","span":{"begin":1168,"end":1176},"obj":"Disease"}],"attributes":[{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T116","span":{"begin":75,"end":80},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T117","span":{"begin":114,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T118","span":{"begin":683,"end":687},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T119","span":{"begin":683,"end":687},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T120","span":{"begin":964,"end":981},"obj":"http://purl.obolibrary.org/obo/UBERON_0000175"},{"id":"T121","span":{"begin":1045,"end":1051},"obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"T122","span":{"begin":1093,"end":1097},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T123","span":{"begin":1093,"end":1097},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":55,"end":60},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T21","span":{"begin":964,"end":981},"obj":"Phenotype"},{"id":"T22","span":{"begin":995,"end":1013},"obj":"Phenotype"}],"attributes":[{"id":"A21","pred":"hp_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/HP_0002202"},{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0031944"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}

{"project":"LitCovid-sentences","denotations":[{"id":"T201","span":{"begin":0,"end":90},"obj":"Sentence"},{"id":"T202","span":{"begin":91,"end":224},"obj":"Sentence"},{"id":"T203","span":{"begin":225,"end":343},"obj":"Sentence"},{"id":"T204","span":{"begin":344,"end":501},"obj":"Sentence"},{"id":"T205","span":{"begin":502,"end":587},"obj":"Sentence"},{"id":"T206","span":{"begin":588,"end":729},"obj":"Sentence"},{"id":"T207","span":{"begin":730,"end":1088},"obj":"Sentence"},{"id":"T208","span":{"begin":1089,"end":1184},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For imaging manifestations, 7 patients in the COVID-19 group showed normal chest CT (10%). COVID-19 patients have a greater number of pure GGO and mixed GGO than non-COVID-19 patients (p = 0.018 and p = 0.001, respectively). For pure GGO lesions, the differences are significant both in peripheral (p = 0.032) and in central areas (p = 0.001). However, the number of mixed GGO is mainly distributed at the periphery in COVID-19 patients (p \u003c 0.001), with no statistical difference in the central area. The consolidation lesions without GGO occurred less in COVID-19 patients (p = 0.001). More lesions are between 1 and 3 cm (p = 0.027), and fewer lesions are larger than half of the lung segment (p = 0.017) in COVID-19 patients. Other significant differences between the two groups include the pleural traction sign (p = 0.019), bronchial wall thickening (p \u003c 0.001), interlobular septal thickening (p = 0.009), crazy paving (p \u003c 0.001), tree-in-bud (p \u003c 0.001), pleural effusions (p \u003c 0.001), pleural thickening (p = 0.030), and the offending vessel augmentation in lesions (p \u003c 0.001). The lung score presents no significant difference between the COVID-19 and non-COVID-19 groups."}